TRABAJOS PRESENTADOS POR EL DR. ALBERTO CORMILLOT Y COLABORADORES EN CONGRESOS INTERNACIONALES

 

MORBID OBESITY: QUALITY OF LIFE AND PSYCHOPATHOLOGY

 

A. Cormillot, R. Zukerfeld, E.Barinaga, R. Medina, W. Leitner, M.A. Erut.

Fundación ALCO, Buenos Aires, Argentina.

8th International Congress on Obesity, Aug-Sept 1998, Paris, France.


The purpose of this study was to examine the quality of life and various psychopathological characteristics in subjects with BMI >40, who attended self-help groups in Buenos Aires. Method: 83 subjects, 80,7% female, X age: 42,5, completed the EAT-26, STAI, BDI (abbrev.), quality of life scale (Nottingham Health Profile, EuroQoL), the Duke Social Support and Stress Scale and were interviewed as per the DSM-IV. Results: According to the established cut-off values (EAT>21, STAI>50, BDI>8), 30.7% of the sample exhibited some kind of eating disorder, 49,4% had anxiety features and 30.1% depressive symptoms. Furthermore, 66% reported lack of energy and 40% social isolation. Total quality of life measured either by questionnaire or structured interview (0 = worst, 100=optimum) was significantly poorer than global self-assessment (44.5 vs 57.7, p< 0.05). No difference was observed on subjective feelings of stress as compared with other chronic disease patients, but perception of support was higher. We detected 30 DSM-IV diagnostic categories, no usually mentioned in the literature, with an increased prevalence of Affective, Anxiety and Eating Disorders and Non-Compliance (Z91.1) on axis I and Borderline Personality Disorder on axis II. Conclusions Morbid obese patients may exhibit more anxiety, depression and eating behavior disorders than other obese patients. Objectively assessed, their quality of life is clearly poorer, but subjects often deny their condition. While feelings of more support may be attributable to their integration into self-help groups, some of them still need psychiatric intervention. This is a differentiated population requiring a psycho-educational approach in order to address obestiy and comorbidity simultaneously, which if overlooked, may hinder the treatment.

Acknowledgements. A.M.Martinez.